SCHEMBL26774247

SCHEMBL26774247

Bc1c(B)c(B)c(-c2c3ccccc3c(-c3ccc4oc5c(-c6ccccc6)ccc(-c6ccccc6)c5c4c3)c3ccccc23)c(B)c1B

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.38
▸ CDC14A Q9UNH5 2/20 0.38
▸ CYP19A1 P11511 2/20 0.35
▸ CYP17A1 P05093 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ WEE1 P30291 1/20 0.34
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ PIM1 P11309 1/20 0.33
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ PRKDC P78527 2/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ CYP1B1 Q16678 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26774399 0.99 CDC14B (0.37) CDC14BCDC14ACYP19A1CYP17A1CYP11B1
SCHEMBL20109987 0.89 CDC14B (0.42) CDC14BCDC14ACYP19A1CYP17A1CYP11B1
SCHEMBL20109993 0.88 CDC14B (0.41) CDC14BCDC14ACYP19A1CYP17A1CYP11B1
SCHEMBL22130579 0.87 PLA2G2A (0.38) CYP19A1WEE1PLA2G2APLA2G4AALOX5
SCHEMBL19784630 0.87 ALOX5 (0.45) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24505859 0.85 CYP1A1 (0.33) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL29321058 0.84 ALOX5 (0.41) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL21252608 0.84 CDC14B (0.46) CDC14BCDC14ACYP19A1CYP17A1CYP11B1
SCHEMBL23341599 0.82 ALOX5 (0.38) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24505906 0.81 ALOX5 (0.45) PLA2G2APLA2G4AALOX5PIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME PPOX, MAP1LC3A, VDAC2 CDC14B 2715/4885CDC14A 2656/4885CYP19A1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback